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Poor adherence to asthma medication treatment is a dilemma as it decreases the chance of achieving and maintaining a proper 
asthma control. Another dilemma is that there seems to be a small range of functional interventions that enhance adherence to long-
term medication treatments. The aim was to review the last five years of published educational interventions for improving adherence 
to asthma medication. Through systematic database searches 20 articles were identified, which matched the inclusion criteria and 
described educational interventions to improve asthma self-management including adherence. The current review showed that 
addressing unintentional non-adherence in terms of incorrect inhaler technique by recurrent education improved the technique 
among many patients, but not among all. Phoning patients, as a means to remove medication beliefs as adherence barriers, seemed 
to be an effective educational strategy, shown as increased adherence. Involving patients in treatment decisions and individualising or 
tailoring educational support also seemed to have favourable effect on adherence. To conclude, addressing specific adherence barriers 
such as poor inhaler technique or medication beliefs could favour adherence. To change adherence behavior, the current review 
proposes that educational adherence support should be a collaborative effort between the patient and the health-care professional 
based on each individual patient’s needs and patient factors, including elements such as personality traits. 
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INTRODUCTION
A plethora of studies have reported about poor adherence to 
asthma medication treatment [1-4]. As an example, an overall 
adherence to asthma medication of 22% in a sample of 5,500 
persons with asthma was reported in one study [5]. People with 
asthma, who display poor medication adherence, most likely 
run increased risk of experiencing poor asthma outcomes [4]. 
The chance of achieving and maintaining the goal of modern 
asthma treatment: a well-controlled asthma, may also diminish 
[6]. There are arguments stating that the discovery of effective 
methods to improve adherence almost certainly would have 
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a more advantageous influence on health than any treatment. 
However, there seems to be a lack of fruitful interventions, which 
successfully improve both adherence and treatment outcome [7]. 
Therefore, the aim was to review the last five years of published 
educational interventions for improving adherence to asthma 
medication. 
Method
Systematic searches were carried out in the databases PubMed, 
Cinahl and Scopus with the following limitations: English language, 
publication between 2007 and 2011, adults (≥18 years) and articles 
accessible in full-text versions. Inclusion criteria were that the 
articles should be based on an empirical intervention including 
efforts to improve adherence in adult persons with asthma. 
Reviews, guidelines and study protocols were excluded. The 
following search terms were used: asthma, adherence, compliance, 
medication and intervention. In PubMed the Mesh terms: 
behavioral medicine, patient education and health psychology 
were used and in Cinahl the heading: medication compliance was 
used. The search terms were used in combinations and together 
with the Boolean operators OR and AND. Twenty articles matched 
the stipulated criteria and were included in the current review. 
Starting point
Thanks to the large body of adherence research conducted in 
recent decades, a rather good picture of factors that influence 
adherence behaviour is obtainable. The World Health Organization 
(WHO) has organized these factors into five dimensions: social/
economic, therapy-related, patient-related, condition-related 
factors and those related to the health-care team and system 
[8]. As efforts to improve adherence are recommended to 
address these dimensions [9], the current review adheres to that 
recommendation and will present the articles accordingly. 
Social and economic factors
In general, the influence of social/economic factors could pose 
challenges to treatment adherence [8, 10], but their effect on 
adherence shows an inconsistent pattern [8] and seems to vary by 
sample [11]. None of the articles included in this review specifically 
addressed this dimension. 
Therapy-related factors
Because asthma medication usually is administered by 
inhalation, the patients need to have an adequate technique 
to allow the medication to deposit in the lungs. Although 
manufacturing companies are striving to develop inhalers that are 
user friendly, incorrect inhaler use seems common [12, 13]. Another 
problem is that many patients seem to be unaware of their 
incorrect inhaler technique [12]. Considering adherence, this could 
be referred to as unintentional non-adherence, which means that 
the patient has an intention to adhere to recommended treatment, 
but fails due to defective inhaler technique [14, 15]. Five of the 
articles included in this review specifically addressed the issue with 
incorrect inhaler technique in their educational interventions.
Interventions to improve inhaler technique
In all five studies improvements in patients’ inhaler technique 
were reported but Hardwell et al. [16] concluded that despite 
improvements the majority still used a faulty technique. The 
interventions were carried out by asthma nurses in two studies [16, 
17], by pharmacists in two studies [18, 19] and by physicians in one 
study [20]. 
Repeated inhaler instructions were used as method to improve 
inhaler technique in three of the studies [16, 19, 20] and in the other 
two studies tailored and individualised educational strategies were 
used [17, 18]. Takemura et al. [20], invited 146 patients of which 
25 received repeated instructions of inhaler use and their inhaler 
technique was checked regularly. The instructions comprised 
verbal information and demonstration provided by their physician. 
In the study conducted by Daiane de Oliveira and colleagues [19], 
patients assigned to the intervention (n=28) received instructions 
on correct use of medication on four occasions, while the control 
group (n=27) only received this information once. Hardwell et 
al. [16] enrolled patients (n=1,092) with uncontrolled asthma 
prescribed pressurised metered-dose inhaler (pMDI) to check 
their inhaler technique using an Aerosol Inhalation Monitor (AIM). 
Patients received specific education on pMDI use, if they failed any 
of the three set AIM parameters. Takemura et al. [20] reported that 
their intervention apart from improving inhaler skills also resulted 
in improvements in self-reported adherence. These findings were 
partly opposed to those reported by Daiane de Oliveira et al. [19], 
who reported that there was no difference between the groups 
as regards reported adherence, but the inhaler technique had 
improved in the intervention group by the end of the project. 
The intervention carried out by Hardwell et al. [16] resulted in 
a statistically significant increase in number of patients with 
appropriate pDMI use after two and three educational occasions, 
but a majority of the patients still used faulty inhaler technique. apallergy.org
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In a randomised controlled trial, a tailor-made intervention, 
depending on the patient’s current asthma control, was used to 
optimise use of asthma medication [18]. The intervention group 
(n=94) received education on three occasions at the pharmacy 
and the control group (n=107) received usual care. The effect 
of this intervention was estimated after six months and was 
described as higher frequency of filled prescriptions and better 
inhaler technique in the intervention group compared to the 
control group. The use of rescue medication was decreased and 
fewer nighttime awakenings were reported in the intervention 
group. However, self-reported adherence was similar in both 
groups [18]. This inconsistency in adherence estimations 
(frequencies of prescription fills and self-reports) sheds light on the 
difficulties with adherence monitoring. 
An individualised education program was used in patients 
defined as “poor adherers to asthma medication” [17]. The 
intervention comprised three individual sessions each lasting 30 
min. In the first session a nurse checked the patient’s knowledge 
and skills about his/her prescribed inhaler. A trained nurse 
informed and demonstrated the skills for self-management of 
asthma including inhaler technique. In the second session, a 
pharmacist informed about dosage, effects and side-effects of 
the medication but also about the method of controlling dosage 
based on asthma symptoms and lung function measured with 
peak expiratory flow (PEF). During the third session, patients 
were provided a self-asthma action plan describing how to 
recognise and to handle an asthma attack. The plan also gave 
clear instructions about how to use the asthma medication, how 
to interpret PEF rates and to avoid triggers. This intervention 
specifically improved both inhaler skills and increased PEF values, 
suggesting that asthma control became better. These effects 
sustained eight weeks after the intervention and this was the last 
follow-up [17].
Patient-related factors
Patients’ perceptions of their asthma and their beliefs about 
asthma medication may influence adherence behaviour [9]. These 
perceptions and beliefs could result in so called intentional non-
adherence, which is a result of a person’s conscious decision to 
deviate from the recommended treatment, for instance by under- 
or overusing the medication or by prematurely terminating 
the treatment [14, 15]. Patients, who deny an asthma diagnosis, 
or patients, who do not perceive their asthma to be a chronic 
condition, seem more inclined to refrain from the medication 
treatment [21]. Medication beliefs are also known to influence 
adherence behavior. For instance, patients who regard the asthma 
medication as a necessity for their health, seem more motivated 
to follow the treatment recommendations [21-23], whereas those 
who are concerned with side-effects or becoming dependent, 
tend to intentionally deviate from the recommendations [21, 23]. 
Patients who have concerns about regular medication intake, 
side-effects or poor effect, also tend to display a non-adherent 
behaviour [24]. In this review, one article specifically addressing 
illness perceptions and four studies addressing medication beliefs 
as a means to improve adherence, were included. 
Illness perceptions
Illness perceptions as factors influencing adherence were 
addressed by Smith et al. [25] who intervened by using a self-
management model of illness comprising a structured step-wise 
and patient-centered approach. The intervention lasted nine 
months and patients were randomised to intervention (n=35) or 
control group (n=56), which received usual care. The health-care 
providers used the model to help the patients to identify areas of 
everyday life when asthma control was difficult to achieve, to set 
goals and to find strategies how to deal with these problematic 
situations. Hereby, the patients were working with personal 
defined goals and strategies. This intervention did not result 
in improved adherence to asthma medication. Instead asthma 
control, asthma self-efficacy and asthma quality of life improved in 
both groups but more in the intervention group.
Medication beliefs
All four studies addressing medication beliefs reported that 
their approaches had a positive impact on medication barriers 
and adherence behaviour. In three studies, telephone calls were 
used as method to carry out the interventions whereas Clerisme-
Beaty and colleagues [26] used quite a different method to 
address adherence and medication beliefs by using a specific drug 
presentation style. The presentation about the drug was aimed at 
increasing patients’ expectancy that the asthma medication could 
control the asthma symptoms adequately. Patients (n=25) who 
received the medication presented in this manner reported better 
adherence and they also expressed higher expectancy with the 
specific asthma medication. 
In a randomised controlled trial [27], the effect of phone 
calls made by pharmacists to patients, who received their 
first prescription for a long-term disease (ten had asthma), apallergy.org
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was evaluated. Two weeks after the patients had filled their 
prescription, a pharmacist phoned the patient to ask if there were 
any problems with the medication, about adherence and whether 
any additional information was needed. The pharmacist gave 
information and advice depending on the patient’s expressed 
needs. Four weeks later a researcher phoned the patients asking 
about the medication and adherence. The intervention of the 
pharmacist calling the patients resulted in better self-reported 
adherence in comparison to the control group. According to the 
result section in the abstract, fewer problems with the medication 
were reported in the intervention group [27]. 
Telephone calls were combined with educational material sent 
by mail on three occasions, in an intervention conducted by Park 
et al. [28]. The study group (n=87) received two telephone calls 
from a trained care manager with a health-care background. The 
phone-calls were concentrated on barriers to asthma medication 
adherence and the development of asthma management 
strategies. The educational mailings comprised general medication 
adherence topics and asthma specific information. Each telephone 
call and mailing did also encourage the participant to carry out 
proper asthma management. The intervention lasted six months 
and resulted in a reduction in both adherence barriers and in days 
when housework and schoolwork were limited due to asthma. 
Additionally, a reduction in the number of days when the patients 
was unable to attend to social, recreational and family activities 
was seen. 
The effect of an “interactive voice recognition call” on adherence 
to asthma medication treatment was evaluated by Bender et al. 
[29]. The intervention group (n=25) received a maximum of three 
robot-phone calls during the intervention period of ten weeks and 
the control group (n=25) received none. By the end of this project, 
the intervention group reported both increased adherence and a 
favourable change in medication beliefs. 
Condition-related factors
The symptom variability characteristic for asthma is claimed to 
be an important barrier to remain in regular medication treatment. 
This typical asthma feature could thus lead to doubts about the 
diagnosis and the need for regular medication treatment [9], 
which may explain why initiated medication treatment sometimes 
is interrupted when the asthma symptoms vanish [22] or when the 
patients start to feel better [30]. On the other hand, an adherent 
behaviour seems more likely to occur among those who perceive 
their asthma as severe [22] but it has also been reported that poor 
adherence frequently occurs among asthmatics with uncontrolled 
disease [31, 32]. Two articles were included in this section of the 
review, of which one succeeded in improving adherence.
Patients with “difficult asthma” were invited to a two phase 
intervention [33]. The first phase comprised a “concordance 
discussion”, which addressed whether the patient was adherent 
or not. Briefly, poor adherence was determined using prescription 
refill frequency, and a plan to address adherence obstacles was 
actively discussed with the appropriate patients. At six months 
follow-up, an improvement in adherence among the patients 
(n=83) was seen, which was associated with improved lung 
function and a reduction of hospital admissions. The second 
phase comprised an individual psycho-educational intervention, 
which was planned in light of the patient’s stated reasons for 
not adhering to the prescribed asthma medication treatment. 
Nine patients were randomised to the intervention and 11 to the 
control group. The effect of the intervention was determined at 12 
months and was seen in an increase in prescriptions filled, as well 
as a reduction in total oral corticosteroid doses taken [33]. 
Patients with moderate and severe asthma (n=333) participated 
in a randomised controlled trial testing whether an individualised 
problem-solving intervention improved adherence to inhaled 
corticosteroids and asthma outcomes [34]. The intervention group 
(n=165) took part in four 30 min sessions aimed at improving 
or maintaining adherence by addressing individual barriers to 
adherence and finding solutions to remove the barriers. The 
control group (n=168) received standard asthma education 
during four 30 min sessions covering asthma topics exclusive 
of adherence. Adherence, which was measured electronically, 
decreased in both groups. In contrast, both asthma control and 
asthma quality of life improved, but emergency department visits 
and hospitalisation were unaffected [34].
Provider-related factors
Patients’ dissatisfaction with the patient-provider interaction 
may have a negative impact on adherence behaviour. Another 
factor related to the health-care system could be that the 
appointments with the physicians are too short to include patient 
education and to provide written information about asthma [9]. 
Patients and physicians seem to have different perceptions about 
the content during appointments. For instance, patients think that 
inhaler technique and side-effects with the asthma medication 
is discussed more rarely than do the physicians [35]. Two of the 
articles included in this review addressed the interaction between apallergy.org
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the patient and the health-care provider and six studies focused 
on patient education. 
Patient-provider interaction
Both studies included in this section of the review focused on 
stimulating to a collaborative effort between the patient and the 
health-care provider to improve adherence to asthma medication. 
The effect of “shared decision making” between the patient and 
clinician as regards asthma medication was investigated in a 
randomised controlled trial. The intervention group (n=182) shared 
in making decisions about the medication, in the other group the 
clinician made the decisions (n=180) and the third group received 
usual care (n=189). At follow-up after one year, the patients, 
who shared in making decisions about their asthma medication 
treatment, improved their adherence based on pharmacy data, 
but at follow-up after two years the intervention effect did not 
occur. Nevertheless, adherence was better at year two compared 
to baseline scores [36]. 
A “cueing therapeutic communication” between patients 
and their clinicians was used to improve adherence to inhaled 
corticosteroids and asthma control in another study. The cue 
intervention comprised of visually standardised interpreted peak 
flow graphs, which were aimed to enhance the communication 
about the patient’s treatment plan. Sixty-eight patients assigned 
to 22 clinicians were randomised to the intervention group and 71 
patients assigned to 21 clinicians to the control group. At the first 
visit the patients received a brief education session and a booklet. 
Adherence was measured electronically but in some cases the 
inhalers’ own dose counters were used. This intervention did not 
improve adherence but it seemed that it had a positive influence 
on asthma control, as patients who participated in the intervention 
used fewer courses of oral steroids during winter and spring, 
reported fewer asthma worsenings and made fewer urgent care 
visits during winter in comparison to the control group. However, 
there was no difference in the patients’ perceptions of the 
communication between the clinicians between the two groups 
[37].
Asthma education
This section of the review comprises articles describing rather 
extensive educational interventions covering important aspects of 
asthma management required for an adequate self-management. 
The two studies in which interventions had a clear effect 
on adherence, were conducted by Morisky et al. [38] and by 
Armour et al. [39]. The first study was a two year prospective 
evaluation of a cohort comprising of 15,275 patients, of which 
35% had asthma. The aim was to determine the effect of a disease 
management program addressing physiological and behavioural 
health indicators by tailored education. The results in the asthma 
subgroup showed significant increase in adherence in relation to 
asthma medication and improved asthma symptoms in regard to 
severity, frequency, nocturnal awakenings and activity limitations. 
Additionally, the patient’s use of PEF monitoring to assess asthma 
was increased [38]. The second study tested the effect of a 
pharmacy asthma care program comprising targeted education 
on the asthma, medication, lifestyle, inhaler technique, adherence, 
medication problems and goal-setting. Fifty pharmacies were 
randomised to the intervention and control pharmacies and 165 
patients completed the intervention and 186 control patients 
finalised the study. The intervention resulted in improved 
adherence to preventer medication and a simultaneous reduction 
in reliever medication use in the intervention group. Moreover, the 
risk of non-adherence decreased and asthma quality of life, asthma 
knowledge and asthma control improved [39].
Three additional studies using educational programs reported 
important progress in self-management but the effect was not 
clearly reflected in adherence behaviour. 
The effect of asthma education in two intervention groups, 
which received specific asthma education comprising elements 
of asthma management, inhaler use techniques as well as 
written information, was investigated by Kritikos et al. [40]. 
In one intervention group, the education was provided by 
specially trained pharmacists and the other group by pharmacist 
researchers trained as asthma educators. The control group did 
only receive written information – the same as in the intervention 
groups. Adherence measured through self-reports improved in 
both intervention groups but not more than in the control group.
In the next study, Wang et al. [41] explored whether there 
were any differences in outcomes if the patients were provided 
with asthma education by a nurse, or asthma counseling by 
a pharmacist. The patients were randomly assigned to two 
intervention groups and one control group. The first intervention 
group (n=35) received education from a nurse including asthma 
knowledge, monitoring disease severity, PEF use, information 
about asthma medication and self-management such as triggers 
and handling asthma attacks. The second group (n=34) received 
the same education in combination with information about 
the function and side-effects of the asthma medication by a apallergy.org
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pharmacist. The control group received usual care. At the last 
follow-up after six months, the two intervention groups had no 
significantly higher adherence compared to the control group. 
The impact of self-management education on adherence to 
asthma medication was studied by Janson et al. [42]. Eighty-
four participants were randomised to an individualised self-
management education (n=45) or to a control group (n=39) 
receiving usual care. The intervention lasted 30 minutes and 
was given on three occasions with two weeks interval. The first 
was held by a nurse and a respiratory therapist both certified as 
asthma educators. There was also a personalised part addressing 
results from spirometry, PEF, skin prick tests and specific strategies 
to remove triggers. Adherence was monitored electronically. Mean 
adherence did not differ between the intervention and the control 
groups. When adherence scores were dichotomised as ≥60% or 
<60%, the odds of maintaining ≥60% adherence was nine-fold for 
the intervention group. These odds were maintained at 24 weeks, 
when the intervention was finalised.
These last three studies considered, a positive effect on patient’s 
asthma knowledge was seen [40-42]. In Wang’s study [41] no 
improvements in asthma quality of life were seen but in Kritikos’ 
study [40] an improvement in both asthma quality of life and 
inhaler technique was found in the intervention groups. Kritikos 
et al. [40] also found a reduction in severe asthma and in Janson’s 
study [42], the intervention group reported fewer symptoms than 
the controls but mean symptom scores decreased in both groups. 
The nocturnal awakenings decreased in the intervention group 
and the odds of experiencing awakenings decreased in this group. 
The use of rescue medication decreased in the intervention group 
versus in the control group but both groups decreased their use 
during the intervention.
The final study had a different approach in comparison with 
the other studies in this section as a learner centered intervention 
was used. The focus was on interactive discussions, problem-
solving, social support and procedures to change asthma specific 
behaviour. Additionally, the participants were encouraged to 
support each other. Twenty-four patients were randomised to the 
intervention group and 21 in the control group. The intervention 
comprised seven weekly meetings lasting two hours. The effect of 
this self-management program was reflected in improved asthma 
knowledge and asthma quality of life, self-efficacy and patient 
activation. As regards use of controller medication the mean was 
already at intervention start 6.8 of a maximum 7 scores, which did 
not leave much space for an improvement [43].
DISCUSSION
With reference to the interventions accounted for in the present 
review, a reasonable conclusion is that stimulating the asthma 
patients to active participation in treatment planning seems to 
improve their self-management of asthma including adherence 
to prescribed asthma medication. As an example, increased 
adherence was seen among patients who shared in decisions 
about medication treatment [36] and among patients, whose 
medication problems and own treatment goals, were considered 
[39]. However, solving the dilemma with poor adherence is not 
that as easy as just engaging the patients, which was learnt from 
the study conducted by Smith et al. [25]. Regardless of ambitious 
efforts, not all interventions accounted for in the current review 
led to improved adherence. In some cases, because the control 
patients also improved their adherence behaviour, which brings to 
mind the famous Hawthorne effect [44].
Another conclusion is that medication barriers, which prevent 
adequate adherence to asthma medication, may be demolished 
by simple phone calls from a health-care professional [27-29]. If we 
could spare a couple of minutes to make a phone call to follow-
up on our asthma patients’ potential medication concerns, we 
may have a cost-effective method to promote adherence, which 
in continuation prevents poor asthma control. Another effective 
method may be to address unintentional non-adherence like 
poor inhaler skills with repeated instructions [16, 19, 20]. It is to be 
noted, as Hardwell et al. [16] put forward, that many patients have 
an incorrect technique despite having received education, which 
recommends that such instructions should be tailored to each 
patient’s ability and that inhaler technique should be checked at 
each health-care appointment. 
Another important remark is that different health-care 
professions have an educational role in promoting adherence 
to medication as part of proper asthma self-management. 
Addressing adherence in various health-care relations and contexts 
may emphasise its importance as the connecting link between 
the prescribed asthma medication and advantageous asthma 
outcomes. This work may be facilitated by identification of persons 
with high probability to display poorer adherence behaviour 
to asthma medication. The tricky part is to estimate accurate 
adherence level and to identify which patients are likely to deviate 
from a prescribed treatment, in daily practice in clinical settings 
[45]. The influence of patients’ personality on health behaviours 
such as adherence to medication treatment could be one guiding apallergy.org
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tool in this aspect. 
Personality could be described in terms of five broad and 
bipolar personality traits Neuroticism, Extraversion, Openness 
to experience, Agreeableness and Conscientiousness. Each 
of the five personality traits are hierarchical constructed by 
more specific personality traits. These five personality traits 
contribute to enduring and individual differences in disposition 
to display a certain behaviour in a given situation [46]. We have 
previously reported that persons with various chronic diseases, 
who scored higher on Neuroticism, lower on Agreeableness or 
lower on Conscientiousness, seemed more inclined to display 
poorer adherence to medication treatment [47]. In yet another 
study, we found that more impulsive young adults with asthma 
reported lower adherence to asthma medication than the less 
impulsive. Young adult men, who were either more antagonistic or 
alexithymic, also reported lower adherence to asthma medication 
[48]. Associations between Neuroticism and poorer adherence in 
men with asthma have also been reported [49]. The advantage of 
assessing personality in relation to adherence is that it provides an 
indication of potential personal needs [50], which could be useful 
targets when planning adherence support. For instance, less 
conscientiousness or impulsive persons, who tend to be less goal-
directed and structured [46], may be less inclined to plan ahead. 
This behavior may not be conducive to regular medication intake. 
For that reason, they may benefit from support with reminders or 
incorporation of routines for their medication intake. In contrast, 
persons scoring high on Neuroticism, who could be described as 
worried and with difficulties handling stress [50], most likely need 
another type of adherence support. 
Some of the interventions in the currently reviewed articles 
were described as individualised for instance in terms of using 
the patients level of asthma knowledge, inhaler or PEF skills as 
points of departures [17] or interpretation of spirometry, PEF rate 
or control over environmental exposures [42], which certainly is of 
significance. Nevertheless, none of the interventions focused on 
individual differences in terms of personality among the selected 
patients, as personality is a major contributor of behavior, including 
health behavior [47, 48]. Fig. 1 shows a hypothetical personality 
perspective on adherence interventions. As a suggestion, future 
interventions aimed at promoting adherence and preventing 
poor asthma control should focus on persons with high risk of 
displaying poor adherence to the prescribed asthma medication 
treatment. In this work, assessment of personality could provide 
a useful tool to identify patients’ different needs and resources 
[50], which could function as targets when planning forthcoming 
adherence support. 
REFERENCES
1.  Latry P, Pinet M, Labat A, Magand JP, Peter C, Robinson P, Martin-
Latry K, Molimard M. Adherence to anti-inflammatory treatment for 
asthma in clinical practice in France. Clin Ther 2008;30:1058-68.
2.  Gamble J, Stevenson M, McClean E, Heaney LG. The prevalence 
of nonadherence in difficult asthma. Am J Respir Crit Care Med 
2009;180:817-22.
3.  Jones C, Santanello NC, Boccuzzi SJ, Wogen J, Strub P, Nelsen LM. 
Adherence to prescribed treatment for asthma: evidence from 
pharmacy benefits data. J Asthma 2003;40:93-101.
4.  Williams LK, Pladevall M, Xi H, Peterson EL, Joseph C, Lafata JE, 
Ownby DR, Johnson CC. Relationship between adherence to inhaled 
corticosteroids and poor outcomes among adults with asthma. J 
Allergy Clin Immunol 2004;114:1288-93.
5.  Bender BG, Pedan A, Varasteh LT. Adherence and persistence with 
fluticasone propionate/salmeterol combination therapy. J Allergy 
Clin Immunol 2006;118:899-904.
6.  Global Strategy for Asthma Management and Prevention, Global 
Initiative for Asthma (GINA). [updated December 2010]; Available 
from: http://www.ginasthma.org. Accessed: 2011-11-18.
7.  Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions 
for enhancing medication adherence. Cochrane Database Syst Rev 
2008:CD000011.
8.  World Health Organization. Adherence to long-term therapies: 
High e￿ect on adherence 
Low e￿ect on adherence
High cost Low cost
Repeated inhaler instructions
Individualised
inhaler
instructions
Self-management
illness  model
Drug  presentation style  
Phone calls
addressing 
medication
beliefs
Individualised
problem-solving
addressing
adherence barriers
Shared decision  making
Patient/provider
interaction  not 
focusing
expressed
personal 
needs
Tailored / 
targeted /
individualised 
educational 
interventions 
Asthma
education
focusing
general
management  
Fig. 1. Hypothetical model suggesting the potential effect of personality 
on adherence interventions, symbolised by dashed arrows.apallergy.org
Axelsson M, et al. 
Asia Pacific
allergy
http://dx.doi.org/10.5415/apallergy.2012.2.1.67 74
evidence for action. Geneva: World Health Organization; 2003. 
9.  O’Donohue WT, Levensky ER. Promoting treatment adherence: a 
practical handbook for health care providers. Thousand Oaks: Sage 
Publications; 2006.
10.  Williams SL, DiMatteo MR, Haskard KB. Psychosocial barriers to 
adherence and lifestyle change. In: Shumaker SA, Ockene JK, Riekert 
KA, editors. The handbook of health behavior change. New York: 
Springer Publishing Company; 2009. p. 445-62.
11.  DiMatteo MR. Variations in patients’ adherence to medical 
recommendations: a quantitative review of 50 years of research. Med 
Care 2004;42:200-9.
12.  Souza ML, Meneghini AC, Ferraz E, Vianna EO, Borges MC. Knowledge 
of and technique for using inhalation devices among asthma 
patients and COPD patients. J Bras Pneumol 2009;35:824-31.
13.  Lavorini F, Magnan A, Dubus JC, Voshaar T, Corbetta L, Broeders 
M, Dekhuijzen R, Sanchis J, Viejo JL, Barnes P, Corrigan C, Levy M, 
Crompton GK. Effect of incorrect use of dry powder inhalers on 
management of patients with asthma and COPD. Respir Med 
2008;102:593-604.
14.  Horne R. Compliance, adherence, and concordance: implications for 
asthma treatment. Chest 2006;130:65S-72S.
15.  Cochrane GM, Horne R, Chanez P. Compliance in asthma. Respir Med 
1999;93:763-9.
16.  Hardwell A, Barber V, Hargadon T, McKnight E, Holmes J, Levy ML. 
Technique training does not improve the ability of most patients to 
use pressurised metered-dose inhalers (pMDIs). Prim Care Respir J 
2011;20:92-6.
17.  Choi JY, Cho Chung HI. Effect of an individualised education 
programme on asthma control, inhaler use skill, asthma knowledge 
and health-related quality of life among poorly compliant Korean 
adult patients with asthma. J Clin Nurs 2011;20:119-26.
18.  Mehuys E, Van Bortel L, De Bolle L, Van Tongelen I, Annemans L, 
Remon JP, Brusselle G. Effectiveness of pharmacist intervention for 
asthma control improvement. Eur Respir J 2008;31:790-9.
19.  Daiane de Oliveira S, Martins MC, Cipriano SL, Pinto RM, Cukier 
A, Stelmach R. Pharmaceutical care for patients with persistent 
asthma: assessment of treatment compliance and use of inhaled 
medications. J Bras Pneumol 2010;36:14-22.
20.  Takemura M, Kobayashi M, Kimura K, Mitsui K, Masui H, Koyama 
M, Itotani R, Ishitoko M, Suzuki S, Aihara K, Matsumoto M, Oguma 
T, Ueda T, Kagioka H, Fukui M. Repeated instruction on inhalation 
technique improves adherence to the therapeutic regimen in 
asthma. J Asthma 2010;47:202-8.
21.  Horne R, Weinman J. Self-regulation and self-management in 
asthma: exploring the role of illness perceptions and treatment 
beliefs in explaining non-adherence to preventer medication. 
Psychol Health 2002;17:17-32.
22.  Ulrik CS, Backer V, Søes-Petersen U, Lange P, Harving H, Plaschke PP. 
The patient’s perspective: adherence or non-adherence to asthma 
controller therapy? J Asthma 2006;43:701-4.
23.  Menckeberg TT, Bouvy ML, Bracke M, Kaptein AA, Leufkens HG, 
Raaijmakers JA, Horne R. Beliefs about medicines predict refill 
adherence to inhaled corticosteroids. J Psychosom Res 2008;64:47-
54.
24.  Choi TN, Westermann H, Sayles W, Mancuso CA, Charlson ME. Beliefs 
about asthma medications: patients perceive both benefits and 
drawbacks. J Asthma 2008;45:409-14.
25.  Smith L, Bosnic-Anticevich SZ, Mitchell B, Saini B, Krass I, Armour C. 
Treating asthma with a self-management model of illness behaviour 
in an Australian community pharmacy setting. Soc Sci Med 
2007;64:1501-11.
26.  Clerisme-Beaty EM, Bartlett SJ, Teague WG, Lima J, Irvin CG, Cohen R, 
Castro M, Wise RA, Rand CS. The Madison Avenue effect: how drug 
presentation style influences adherence and outcome in patients 
with asthma. J Allergy Clin Immunol. 2011;127:406-11.
27.  Elliott RA, Barber N, Clifford S, Horne R, Hartley E. The cost 
effectiveness of a telephone-based pharmacy advisory service to 
improve adherence to newly prescribed medicines. Pharm World Sci 
2008;30:17-23.
28.  Park J, Jackson J, Skinner E, Ranghell K, Saiers J, Cherney B. Impact 
of an adherence intervention program on medication adherence 
barriers, asthma control, and productivity/daily activities in patients 
with asthma. J Asthma 2010;47:1072-7.
29.  Bender BG, Apter A, Bogen DK, Dickinson P, Fisher L, Wamboldt FS, 
Westfall JM. Test of an interactive voice response intervention to 
improve adherence to controller medications in adults with asthma. 
J Am Board Fam Med 2010;23:159-65.
30.  Laforest L, El Hasnaoui A, Pribil C, Ritleng C, Osman LM, Schwalm MS, 
Le Jeunne P, Van Ganse E. Asthma patients’ self-reported behaviours 
toward inhaled corticosteroids. Respir Med 2009;103:1366-75.
31.  Bender BG, Long A, Parasuraman B, Tran ZV. Factors influencing 
patient decisions about the use of asthma controller medication. 
Ann Allergy Asthma Immunol 2007;98:322-8.
32.  Adams RJ, Appleton S, Wilson DH, Ruffin RE. Participatory decision 
making, asthma action plans, and use of asthma medication: a 
population survey. J Asthma 2005;42:673-8.
33.  Gamble J, Stevenson M, Heaney LG. A study of a multi-level 
intervention to improve non-adherence in difficult to control 
asthma. Respir Med 2011;105:1308-15.
34.  Apter AJ, Wang X, Bogen DK, Rand CS, McElligott S, Polsky D, 
Gonzalez R, Priolo C, Adam B, Geer S, Ten Have T. Problem solving 
to improve adherence and asthma outcomes in urban adults with 
moderate or severe asthma: a randomized controlled trial. J Allergy 
Clin Immunol 2011;128:516-23.e1-5.
35.  Canonica GW, Baena-Cagnani CE, Blaiss MS, Dahl R, Kaliner MA, 
Valovirta EJ. Unmet needs in asthma: Global Asthma Physician and 
Patient (GAPP) Survey: global adult findings. Allergy 2007;62:668-74.
36.  Wilson SR, Strub P, Buist AS, Knowles SB, Lavori PW, Lapidus J, Vollmer 
WM. Shared treatment decision making improves adherence and 
outcomes in poorly controlled asthma. Am J Respir Crit Care Med 
2010;181:566-77.
37.  Janson SL, McGrath KW, Covington JK, Baron RB, Lazarus SC. 
Objective airway monitoring improves asthma control in the cold 
and flu season: a cluster randomized trial. Chest 2010;138:1148-55.apallergy.org
Recent adherence interventions in asthmatics
http://dx.doi.org/10.5415/apallergy.2012.2.1.67 75
38.  Morisky DE, Kominski GF, Afifi AA, Kotlerman JB. The effects of a 
disease management program on self-reported health behaviors 
and health outcomes: evidence from the “Florida: a healthy state 
(FAHS)” Medicaid program. Health Educ Behav 2009;36:505-17.
39.  Armour C, Bosnic-Anticevich S, Brillant M, Burton D, Emmerton L, 
Krass I, Saini B, Smith L, Stewart K. Pharmacy Asthma Care Program 
(PACP) improves outcomes for patients in the community. Thorax 
2007;62:496-502.
40.  Kritikos V, Armour CL, Bosnic-Anticevich SZ. Interactive small-group 
asthma education in the community pharmacy setting: a pilot study. 
J Asthma 2007;44:57-64.
41.  Wang KY, Chian CF, Lai HR, Tarn YH, Wu CP. Clinical pharmacist 
counseling improves outcomes for Taiwanese asthma patients. 
Pharm World Sci 2010;32:721-9.
42.  Janson SL, McGrath KW, Covington JK, Cheng SC, Boushey HA. 
Individualized asthma self-management improves medication 
adherence and markers of asthma control. J Allergy Clin Immunol 
2009;123:840-6.
43.  Tousman SA, Zeitz H, Bond D, Stewart D, Rackow R, Greer R, Hatfield 
S, Layman K, Ganjwala P. A randomized controlled behavioral trial of 
a new adult asthma self-management program. J Asthma Allergy 
Educ 2011;2:91-6.
44.  Gillespie R. Manufacturing knowledge: a history of the Hawthorne 
experiments. Cambridge: Cambridge University Press; 1991.
45.  Otsuki M, Clerisme-Beaty E, Rand CS, Riekert KA. Measuring 
adherence to medication regimens in clinical care and research. In: 
Shumaker SA, Ockene JK, Riekert KA, editors. The handbook of health 
behavior change. New York: Springer Publishing Company; 2009. p. 
309-25.
46.  McCrae RR, Costa PT Jr. Personality in adulthood: a five-factor theory 
perspective. 2nd ed. New York: Guilford Press; 2003.
47.  Axelsson M, Brink E, Lundgren J, Lötvall J. The influence of personality 
traits on reported adherence to medication in individuals with 
chronic disease: an epidemiological study in West Sweden. PloS One 
2011;6:e18241.
48.  Axelsson M, Emilsson M, Brink E, Lundgren J, Torén K, Lötvall J. 
Personality, adherence, asthma control and health-related quality of 
life in young adult asthmatics. Respir Med 2009;103:1033-40.
49.  Emilsson M, Berndtsson I, Lötvall J, Millqvist E, Lundgren J, Johansson 
A, Brink E. The influence of personality traits and beliefs about 
medicines on adherence to asthma treatment. Prim Care Respir J 
2011;20:141-7.
50.  Costa PT, McCrae RR. Revised NEO Personality Inventory (NEO-
PI-R) and NEO Five-Factor Inventory (NEO-FFI) professional manual. 
Odessa: Psychological Assessment Resources; 1992.